Department Of Clinical Research 1
1. Unassigned Complex Unique Recombinant Forms Related to CRF36_cpx in Children Identified in an HIV-1 Outbreak in Pakistan
2. Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study
3. Estimates, trends, and drivers of the global burden of type 2 diabetes attributable to PM2·5 air pollution, 1990–2019: an analysis of data from the Global Burden of Disease Study 2019
4. Global, regional, and national stillbirths at 20 weeks gestation or longer in 204 countries and territories, 1990–2021: findings from the Global Burden of Disease Study 2021
5. Global, regional, and national burden of Chagas disease, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023
6. Phylogenetic and drug- and vaccine-resistance profiles of Hepatitis B Virus among children with HIV co-infection in Pakistan
7. Global, regional, and national burden of low back pain, 1990–2020, its attributable risk factors, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021
8. Prevalence, years lived with disability, and trends in anaemia burden by severity and cause, 1990–2021: findings from the Global Burden of Disease Study 2021
9. Burden of chronic respiratory disease in Asia, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023
10. Sputum culture reversion in longer treatments with bedaquiline, delamanid, and repurposed drugs for drug-resistant tuberculosis
11. Author Correction: Elucidating causative gene variants in hereditary Parkinson’s disease in the Global Parkinson’s Genetics Program (GP2) (npj Parkinsons Disease, (2023), 9, 1, (100), 10.1038/s41531-023-00526-9)
12. A global action agenda for turning the tide on fatty liver disease
13. Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
14. Global, regional, and national burden of asthma and atopic dermatitis, 1990–2021, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021
15. Global prevalence, cascade of care, and prophylaxis coverage of hepatitis B in 2022: a modelling study
16. Outcomes of WHO-conforming, longer, all-oral multidrug-resistant TB regimens and analysis implications
17. Effect of smoking on drug-resistant tuberculosis treatment outcomes and potential mechanistic pathways: a multicountry cohort study
18. Challenges for Developing Palliative Care Services in Resource- Limited Settings of Kazakhstan
19. Cost-Effectiveness of Hospice Palliative Care for Patients With Cancer and Family Caregivers: A Multicenter Study in Kazakhstan
20. Improving palliative care outcomes in remote and rural areas of LMICs through family caregivers: lessons from Kazakhstan
21. Estimating Post-treatment Recurrence After Multidrug-Resistant Tuberculosis Treatment Among Patients With and Without Human Immunodeficiency Virus: The Impact of Assumptions About Death and Missing Follow-up
22. Defining the causes of sporadic Parkinson’s disease in the global Parkinson’s genetics program (GP2)
23. Effectiveness of Bedaquiline Use beyond Six Months in Patients with Multidrug-Resistant Tuberculosis
24. Effectiveness of a bedaquiline, linezolid, clofazimine ‘core’ for multidrug-resistant TB
25. Characterising acute and chronic care needs: insights from the Global Burden of Disease Study 2019
26. Characterising acute and chronic care needs: insights from the Global Burden of Disease Study 2019
1